[Frontiers in Bioscience 2, d353-379, July 15, 1997]

	[Frontiers in Bioscience 2, d353-379, July 15, 1997] Reprints PubMed CAVEAT LECTOR
	APOPTOSIS IN TUMORIGENESIS AND CANCER THERAPY Gaèl McGill and David E. Fisher Division of Pediatric Hematology/Oncology, Dana Farber Cancer Institute and Children's Hospital, Harvard Medical School, 44 Binney St., Boston, MA 02115 Received 6/15/97 Accepted 6/28/97 6. ACKNOWLEDGMENTS We wish to acknowledge and apologize to all those whose work in the field was not directly referenced here. G.M. is a predoctoral fellow of the Howard Hughes Medical Institute and a Sandoz Fellow. D.E.F. is supported by grants from the NIH and is Fellow of the Pew Foundation and the James S. McDonnell Foundation.

[Frontiers in Bioscience 2, d353-379, July 15, 1997]
Reprints
PubMed
CAVEAT LECTOR

APOPTOSIS IN TUMORIGENESIS AND CANCER THERAPY
Gaèl McGill and David E. Fisher
Division of Pediatric Hematology/Oncology, Dana Farber Cancer Institute and Children's Hospital, Harvard Medical School, 44 Binney St., Boston, MA 02115

Received 6/15/97 Accepted 6/28/97

6. ACKNOWLEDGMENTS

We wish to acknowledge and apologize to all those whose work in the field was not directly referenced here. G.M. is a predoctoral fellow of the Howard Hughes Medical Institute and a Sandoz Fellow. D.E.F. is supported by grants from the NIH and is Fellow of the Pew Foundation and the James S. McDonnell Foundation.